Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisPatricia Cortazar, Gϋnter von Minckwitz, David Cameron et al.|The Lancet|2014Cited by 4.7k
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys‐Paluchowski, Maria Luisa Gasparri, Jana de Boniface et al.|Cancers|2021Cited by 159
Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomyWilliam P. Weber, Visnu Lohsiriwat, Martin Haug et al.|Breast Cancer Research and Treatment|2018Cited by 123
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus PaperBernhard Wörmann, Ralf‐Dieter Hofheinz, Carsten Bokemeyer et al.|Oncology Research and Treatment|2020Cited by 88